Page last updated: 2024-08-23

epirubicin and Leukemia, Myelomonocytic, Acute

epirubicin has been researched along with Leukemia, Myelomonocytic, Acute in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Damon, L; Demirer, T; Derigs, G; Ferrante, P; Kröger, N; Rosti, G; Wandt, H; Zander, AR	1
Bonneterre, JM	1
Ikuta, K; Kajigaya, Y; Matsuyama, S; Sasaki, H	1

Reviews

1 review(s) available for epirubicin and Leukemia, Myelomonocytic, Acute

Article	Year
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Bone marrow transplantation, 2003, Volume: 32, Issue:12 Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous	2003

Article

Year

Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.

Bone marrow transplantation, 2003, Volume: 32, Issue:12

Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous

2003

Trials

1 trial(s) available for epirubicin and Leukemia, Myelomonocytic, Acute

Article	Year
Long-term efficacy and toxicity of the FEC100 regimen. Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:14 Suppl 1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cost-Benefit Analysis; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Costs; Epirubicin; Female; Fluorouracil; Heart Diseases; Humans; Leukemia, Myelomonocytic, Acute; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Treatment Outcome	2004

Article

Year

Long-term efficacy and toxicity of the FEC100 regimen.

Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:14 Suppl 1

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cost-Benefit Analysis; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Costs; Epirubicin; Female; Fluorouracil; Heart Diseases; Humans; Leukemia, Myelomonocytic, Acute; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Treatment Outcome

2004

Other Studies

1 other study(ies) available for epirubicin and Leukemia, Myelomonocytic, Acute

Article	Year
[Cell differentiation action of 4'-epi-adriamycin in WEHI-3B myelomonocytic leukemia cells]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:14 Topics: Animals; Cell Differentiation; Epirubicin; Leukemia, Myelomonocytic, Acute; Mice; Mice, Inbred BALB C; Tumor Cells, Cultured	1991